Critical Analysis of the Article “Epidemiological Aspects and Anti-SARS-CoV-2 Antibodies”

Authors

Keywords:

#covid19; #lettertotheeditor

Downloads

Download data is not yet available.

References

1. Romero Gavilán S, Moscoso García LU, Chuchón Gómez JA, Paredes Morales RW, Rodríguez Puga R. Aspectos epidemiológicos y presencia de anticuerpos neutralizantes anti-SARS-CoV-2 posvacunación en pacientes sin antecedentes de COVID-19. Rev Cubana Med. 2025 [acceso 28/04/2025];64. Disponible en: https://revmedicina.sld.cu/index.php/med/article/view/3631/2544

2. Pourhoseingholi MA, Vahedi M, Rahimzadeh M. Cálculo del tamaño de la muestra en estudios médicos. Gastroenterol Hepatol Cama Lab. 2013;6(1):14-17.

3. Arrogante O. Técnicas de muestreo y cálculo del tamaño muestral. Enferm Intensiva. 2021;32(1):44-50. DOI: https://doi.org/10.1016/j.enfi.2020.05.003.

4. Martínez BAF, Leotti VB, Silva GSE, Nunes LN, Machado G, Corbellini LG ¿Razón de probabilidades o razón de prevalencia? Una visión general de los métodos estadísticos reportados y la pertinencia de las interpretaciones en estudios transversales con resultados dicotómicos en medicina veterinaria. Front Vet Sci. 2017;4:193. DOI: https://doi.org/10.3389/fvets.2017.00193

5. Rodrigues CF, Lima FJ, Barbosa FT. Importancia del uso adecuado de la estadística básica en la investigación clínica. Rev Bras Anestesiol. 2017;67(6):619-25. DOI: https://doi.org/10.1016/j.bjane.2017.01.011

6. Cvetković Vega A, Maguiña JL, Soto A, Lama-Valdivia J, Correa López LE. Cross-sectional studies. Estudios Transversales. Rev Fac Med Humana. 2021 [acceso 28/04/2025];21(1):164-70. Disponible en: http://www.scielo.org.pe/pdf/rfmh/v21n1/2308-0531-rfmh-21-01-179.pdf

7. Hulley SB, Cummings SR, Browner WS, Grady DG, Newman TB. Diseño de investigaciones clínicas. 4.ª ed. Editorial Médica Panamericana; 2015. Park SH, Han K. How to Clearly and Accurately Report Odds Ratio and Hazard Ratio in Diagnostic Research Studies? Korean J Radiol. 2022 Aug;23(8):777-84. DOI: https://doi.org/10.3348/kjr.2022.0249

Downloads

Published

2026-05-15

How to Cite

1.
Díaz Vergara FJ, Aliaga Chávez AN, Bustamante Gonzales R. Critical Analysis of the Article “Epidemiological Aspects and Anti-SARS-CoV-2 Antibodies” . Rev Cubana Med [Internet]. 2026 May 15 [cited 2026 May 19];65. Available from: https://revmedicina.sld.cu/index.php/med/article/view/5150

Issue

Vol. 65 (2026): publicación continua

Section

Letters

License

Copyright (c) 2026 Félix Jesús Díaz Vergara, Almendra Nicoll Aliaga Chávez, Rossycela Bustamante Gonzales

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

The Cuban Journal of Medicine protects the author's patrimonial rights. However, it is licensed under a Creative Commons Licensehttps://creativecommons.org/licenses/by-nc/4.0/deed.es_ES which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided that the primary source of publication is duly cited. The author always retains his moral rights.

 

You are free to:

- Share - copy and redistribute the material in any medium or format.

- Adapt - remix, transform and build upon the material

- The license cannot revoke these freedoms as long as you follow the terms of the license.

Under the following terms:

- Attribution - You must give proper credit, provide a link to the license, and indicate if changes have been made. You may do so in any reasonable manner, but not in such a way as to suggest that you or your use is supported by the licensor.

- Non-Commercial Purpose- You may not make use of the material for commercial purposes.

- No Additional Restrictions - You may not apply legal terms or technological measures that legally restrict others from making any use permitted by the license.